OR WAIT null SECS
Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.
Activation and expansion are essential for success in both autologous and allogeneic therapies.
Continuous manufacturing and a quality-by-design development approach are a natural fit.
September 03, 2020
Tight development timelines and accelerated approval pathways favor simple, cost-effective capsule formulations.
The general principle of lyophilization has hardly changed, but significant advances have occurred in process and product attribute understanding.
September 02, 2020
The companies have entered into a strategic partnership for the CMC development and manufacturing of Ansun’s biologics pipeline.
Supply chain traceability is essential in the manufacture of APIs to assure safety and quality.
End-user considerations are becoming increasingly important as they can provide a lot of value and help to ensure commercial success of a drug.
August 28, 2020
The collaboration includes an integrated program that encompasses formulation development, drug substances, and drug product manufacturing.
The register supports cross-functional teams of chemists and biologists in developing non-natural, chemically-modified therapeutics for drug discovery.
AbCellera’s recent acquisition of the OrthoMab bispecific platform is expected to accelerate antibody product development.
August 20, 2020
Avacta Group has expanded its drug development partnership with LG Chem Life Sciences to include new programs incorporating Avacta’s Affimer XT technology.
August 13, 2020
Veklury (remdesivir) is an investigational antiviral drug that Gilead is developing to treat COVID-19.